Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT05274451
What this trial is testing

Investigate LYL797 in Adults With Solid Tumors

Who this might be right for
Triple Negative Breast CancerTNBC - Triple-Negative Breast CancerNon-small Cell Lung Cancer+20 more
Lyell Immunopharma, Inc. 57
Early research (Phase 1)Study completedNCT00014456
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerCarcinoma of Unknown Primary+9 more
Dartmouth-Hitchcock Medical Center 35
Testing effectiveness (Phase 2)Study completedNCT00191373
What this trial is testing

A Trial for HER2 Positive Breast Cancer Patients With Metastatic Disease

Who this might be right for
Breast NeoplasmsCancer of the BreastBreast Cancer
Eli Lilly and Company 66
Testing effectiveness (Phase 2)Ended earlyNCT00465673
What this trial is testing

Liposomal Doxorubicin (Lipo-Dox) in Patients With Brain Metastasis From Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2
Not applicableStudy completedNCT07418411
What this trial is testing

Additional Imaging Methods for Assessing Axillary Lymph Node Involvement in Breast Cancer

Who this might be right for
Breast CancerAxillary Lymph Node Metastasis
Institute of Oncology Ljubljana 180
Early research (Phase 1)Study completedNCT01640665
What this trial is testing

Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors

Who this might be right for
Metastatic Breast CancerGastrointestinal Tumors
Yale University 24
Very early researchEnded earlyNCT04712721
What this trial is testing

Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.

Who this might be right for
Glioblastoma MultiformeBrain NeoplasmsGastroesophageal Adenocarcinoma+1 more
Novartis Pharmaceuticals 14
Not applicableWithdrawnNCT03974204
What this trial is testing

Analyses of Exosomes in the Cerebrospinal Fluid for Breast Cancer Patients With Suspicion of Leptomeningeal Metastasis.

Who this might be right for
Breast CancerLeptomeningeal Metastasis
Centre Oscar Lambret
Not applicableLooking for participantsNCT07415564
What this trial is testing

Symptom Management and Survivorship Plus Coaching for Advanced Cancer Survivors and Their Caregivers

Who this might be right for
Cancer MetastaticSymptoms and SignsQuality of Life
University of Arizona 200
Early research (Phase 1)Ended earlyNCT03145909
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 19
Large-scale testing (Phase 3)UnknownNCT04736186
What this trial is testing

Prevention and Treatment of Pyrrolitinib-associated Diarrhea

Who this might be right for
Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 470
Testing effectiveness (Phase 2)Study completedNCT00243503
What this trial is testing

Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Pfizer 60
Testing effectiveness (Phase 2)UnknownNCT05141630
What this trial is testing

Axillary Sentinel or Targeted Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy in Node-positive Breast Cancer

Who this might be right for
Breast Cancer Female
Fudan University 100
Large-scale testing (Phase 3)Study completedNCT02716792
What this trial is testing

Evaluate Renal Safety of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Disease Due to Breast Cancer

Who this might be right for
Pain; Bone Neoplasms; Neoplasm Metastasis
Hoffmann-La Roche 334
Testing effectiveness (Phase 2)UnknownNCT05075512
What this trial is testing

The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer

Who this might be right for
Breast Neoplasm Female
Zhejiang Cancer Hospital 40
Not applicableStudy completedNCT01730365
What this trial is testing

Optical Detection of Malignancy During Percutaneous Interventions

Who this might be right for
Pulmonary Coin LesionColon Cancer Liver MetastasisBreast Cancer
Philips Healthcare 104
Testing effectiveness (Phase 2)Study completedNCT00347919
What this trial is testing

Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 189
Large-scale testing (Phase 3)Study completedNCT01645839
What this trial is testing

Interest of Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte®) in Meningeal Metastasis of Breast Cancer

Who this might be right for
Breast CancerLeptomeningeal Metastases
Centre Oscar Lambret 74
Testing effectiveness (Phase 2)Study completedNCT00072865
What this trial is testing

Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast CancerNeoplasm Metastasis
Eli Lilly and Company 50
Testing effectiveness (Phase 2)Study completedNCT00371254
What this trial is testing

Dasatinib (BMS-354825) in Patients With Advanced 'Triple-negative' Breast Cancer

Who this might be right for
Breast CancerMetastasis
Bristol-Myers Squibb 55
Next Page